Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Zhejiang took the lead in exploring the EOD model system. Recently, the Provincial Department of Ecology and Environment, the Provincial Development and Reform Commission, the Zhejiang Branch of CDB and the Zhejiang Branch of Agricultural Development Bank jointly issued the Guidelines for the Storage of Zhejiang Eco-environment-oriented Development (EOD) Projects (Trial), the Management Regulations of Zhejiang Eco-environment-oriented Development (EOD) Projects (Trial), and the Implementation Evaluation Rules of Zhejiang Eco-environment-oriented Development (EOD) Projects (Trial) EOD model is an innovation of market-oriented eco-environmental governance model, which aims to promote the effective integration, value-added feedback and overall promotion of eco-environmental governance with strong public welfare and related industries with good returns, and realize the integrated development of regional eco-environmental governance and industries. At present, 18 EOD projects in the province have been included in the financial support project library of the Ministry of Ecology and Environment, and two batches of 18 provincial pilot EOD projects have been announced. (released by Zhejiang)Pakistan KSE-100 index rose 0.8% to 110,933.10.
"Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.US prosecutors have filed murder charges against the suspect in the murder of a joint health executive.The turnover of Shanghai and Shenzhen stock markets exceeded 1.5 trillion yuan for the third consecutive trading day.
The turnover of Shanghai and Shenzhen stock markets exceeded 1.5 trillion yuan for the third consecutive trading day.The interest rates of 10-year treasury bonds and CDB active bonds all went down by about 5bp, while those of 24 interest-bearing treasury bonds went down by 4.9bp to 1.856%, and those of 24 CDB dropped by 5.25bp to 1.9175%.Gaode Infrared sued six former employees and their new owners for infringing on business secrets. The other company: Gaode Infrared announced that there were "false records and false statements". On the evening of December 5, Gaode Infrared announced that the company filed a civil lawsuit against Zhejiang Juexin Microelectronics Co., Ltd. (hereinafter referred to as Juexin Company), Mao Jianhong and six former employees for infringing on the company's business secrets, asking the defendant to pay 200 million yuan in economic losses and other things. On December 6th and 9th, Juexin Company issued statements on the announcement of Gaode Infrared on WeChat WeChat official account "Juexin Microelectronics", claiming that there were "false records, false statements, misleading statements or major omissions" in the above announcement of Gaode Infrared. (per warp net)
Strategy guide 12-13
Strategy guide
Strategy guide
12-13